Events

Emerging strategies for the development of novel Radioligand Therapies.
The history of immunotherapy and other targeted therapies for the treatment of cancer.
The intersection of lifestyle, modification, control of factors that impact the development of artherosclerosis and other metabolic disorders with the risk of cancer.

Program Directors:
Thomas J. Lomis, M.D., M.S.
Mark Pegram M.D.

Planning Committee
Steven Rowe M.D., Ph.D.
Frankis Almaguel M.D., Ph.D.

Includes breakfasts, lunches, dinner and cocktail reception.